Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Ottobock SE & Co. KGaA (OBCKF) vs. Competitors

2 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
OBCKFOttobock SE & Co. KGaA$8,536.90$2.82B―0.00%Strong BuyUnlock the OBCKF analyst price target with TipRanks PremiumOBCKFUnlock the OBCKF top-analyst price target with TipRanks Premium
DE:AFXCarl Zeiss MeditecEUR 35.00EUR 3.13B20.96-19.76%Moderate SellUnlock the DE:AFX analyst price target with TipRanks PremiumOBCKF vs DE:AFXUnlock the DE:AFX top-analyst price target with TipRanks Premium
DE:COPCompuGroup MedicalEUR 28.20EUR 1.49B43.4219.59%―Unlock the DE:COP analyst price target with TipRanks PremiumOBCKF vs DE:COPUnlock the DE:COP top-analyst price target with TipRanks Premium
DE:DRW3Draegerwerk AG & Co. KGaAEUR 112.00EUR 1.82B12.3959.54%Moderate BuyUnlock the DE:DRW3 analyst price target with TipRanks PremiumOBCKF vs DE:DRW3Unlock the DE:DRW3 top-analyst price target with TipRanks Premium
DE:EUZEckert & Ziegler Strahlen und MedizintechnikEUR 15.34EUR 959.88M17.63-8.96%Moderate BuyUnlock the DE:EUZ analyst price target with TipRanks PremiumOBCKF vs DE:EUZUnlock the DE:EUZ top-analyst price target with TipRanks Premium
DE:SBSSTRATEC BiomedicalEUR 27.90EUR 339.15M-7.9931.29%Moderate BuyUnlock the DE:SBS analyst price target with TipRanks PremiumOBCKF vs DE:SBSUnlock the DE:SBS top-analyst price target with TipRanks Premium

Performance Comparison

-50%-25%0%25%50%75%100%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
OBCKFOttobock SE & Co. KGaA8536.900.000.00%
DE:AFXCarl Zeiss Meditec35.00-5.49-13.56%
DE:COPCompuGroup Medical28.205.0221.64%
DE:DRW3Draegerwerk AG & Co. KGaA112.0045.4368.24%
DE:EUZEckert & Ziegler Strahlen und Medizintechnik15.34-0.52-3.29%
DE:SBSSTRATEC Biomedical27.907.9439.78%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts